MESO
MesoblastDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MESO vs peer average
28/100
MESO vs. peer average (D vs. C)
Grade spread
A 1 · B 3 · C 2 · D 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
VRDN is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $2.12B
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MESO
Mesoblast
VRDN
Viridian Therapeutics
Grade
D
A
Momentum
50
38
Value
41
41
Sentiment
-
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs VRDN
MESO / VRDN
Grade Position
Below peers
MESO vs. peer average (D vs. C)
28/100
Momentum
50
MESOValue
41
MESOSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MESO
VRDN is the first peer returned for this comparison set.